Open account
Sign up/Log in
PETROS PHARMACEUTICALS INC: NEW COLLABORATION WITH LEMONAID HEALTH
Reuters · 3d ago
Column: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Ask class members.
Alison Frankel: Law firm Edelson pitches radical idea for picking lead in 23andMe case. Frankel says plaintiffs have a say in picking lawyers to lead consolidated cases. She says firm hired professors to survey prospective class members about what they want. Franelson says class members want transparency, a quick settlement, a lean, efficient leadership team.
Reuters · 04/18 22:37
BUZZ-U.S. STOCKS ON THE MOVE-Ibotta, Blackstone, US health insurers
Wall Street's main stock indexes gained on Thursday. Dow Jones Industrial Average was up 0.11% at 37,793.34. Top three S&P 500 percentage gainers: Estee Lauder, United Airlines, Genuine Parts. Top two Nasdaq percentage losers: Las Vegas Sands and Tesla.
Reuters · 04/18 17:35
BUZZ-U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands
Dow Jones Industrial Average was up 0.52% on Thursday. The benchmark S&P 500 and the Nasdaq were subdued as higher Treasury yields pressured equities. Zscaler, Las Vegas Sands, 23andMe and Ally Financial were among the day's top stocks.
Reuters · 04/18 16:32
BUZZ-Genetic testing firm 23andMe rises after CEO considers taking firm private
Genetic testing firm 23andMe's ME.O shares rise 40.3% to 50 cents. CEO Anne Wojcicki is considering making an offer to buy 23andme in a potential go-private transaction. Co says CEO owns more than 20% of company's outstanding shares.
Reuters · 04/18 14:26
23ANDME SHARES UP 24.9% AFTER CEO CONSIDERS TAKING FIRM PRIVATE
Reuters · 04/18 13:50
BUZZ-U.S. STOCKS ON THE MOVE-D.R. Horton, 23andMe, Copper miners
D.R. Horton, 23andMe, Copper miners rise as chip stocks rebound. Dow e-minis expected to open higher on Thursday. Investors await commentary from Federal Reserve officials on outlook for interest-rate cuts. 23andme rises after CEO considers taking firm private.
Reuters · 04/18 13:13
BUZZ-Genetic testing firm 23andMe extends gains after CEO considers taking firm private
Genetic testing firm 23andMe's ME.O shares extend gains to rise as much as 34.7% to $0.48 premarket. CEO Anne Wojcicki is considering taking firm private. Company says CEO owns more than 20% of the company's shares.
Reuters · 04/18 12:44
Webull offers 23andMe Holding Co stock information, including NASDAQ: MEUSW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEUSW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading MEUSW stock methods without spending real money on the virtual paper trading platform.